Flexion Therapeutics to Present at the 2021 Raymond James Human Health Innovation Conference
14 Giugno 2021 - 10:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that
Michael Clayman, M.D., President and Chief Executive Officer, will
participate in an analyst-led fireside chat at the 2021 Raymond
James Human Health Innovation Conference. The virtual fireside chat
is scheduled to begin at 3:20 p.m. ET on Monday, June 21,
2021.
To access the live webcast of the presentation, please visit the
Flexion website at http://ir.flexiontherapeutics.com.
About Flexion TherapeuticsFlexion Therapeutics
(Nasdaq:FLXN) is a biopharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of people with musculoskeletal conditions, beginning with
osteoarthritis, the most common form of arthritis. The Company's
core values are focus, ingenuity, tenacity, transparency and fun.
Please visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Grafico Azioni Flexion Therapeutics (NASDAQ:FLXN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Flexion Therapeutics (NASDAQ:FLXN)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Flexion Therapeutics Inc (NASDAQ): 0 articoli recenti
Più Articoli Notizie